Access cutting-edge atherosclerosis treatment through this clinical trial at a research site in Merritt Island. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Merritt Island location
Preparing your pre-screening questions…
Access atherosclerosis specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atherosclerosis treatment provided free
Check if you qualify for this atherosclerosis clinical trial in Merritt Island, FL
No-Cost Study Care
Local to Merritt Island
Convenient for FL residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Lipoprotein(a), also known as Lp(a), is a protein that carries cholesterol and proteins in your blood. People with high Lp(a) have a higher risk for heart disease. The main purpose of the study is to investigate how lepodisiran, compared to a placebo, affects the amount and type of plaque in the heart's vessels using an imaging technology known as Coronary Computed Tomography Angiography (CCTA) in adults who have high levels of Lp(a). Participation will last about 120 weeks.
Sponsor: Eli Lilly and Company
Yes, this clinical trial (NCT07613294) has an active research site in Merritt Island, FL that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for atherosclerosis treatment options in Merritt Island, FL, this clinical trial (NCT07613294) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Merritt Island research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atherosclerosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.